Discover 1,672 paid clinical trials in Sandy Springs, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,672
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Atlanta GA, Nashville TN, Chapel Hill NC, Tampa FL,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
for
Breast Cancer Metastatic
Location: Atlanta GA, Rochester NY, New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06750484
Phase 2, Recruiting
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
for
Glioblastoma, Recurrent Glioblastoma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT04590664
Phase 1, Phase 2, Recruiting
A Web-Based Dyadic Intervention for Colorectal Cancer
for
Colorectal Carcinoma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT05663203
Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Atlanta GA, Greenville SC, Knoxville TN, Birmingham AL,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Use of Repris Needle in Bladder Injection
for
Overactive Bladder Syndrome
Location: Cartersville GA
Sponsor: Uro-1 Medical
Sex: Female
Age: 18+
Code: NCT04982120
Recruiting
Pompe Pregnancy Sub-Registry
for
Glycogen Storage Disease Type II (GSD-II),
Location: Atlanta GA, Greenville SC, Jacksonville FL, Durham NC,
Sponsor: Genzyme, a Sanofi Company
Sex: Female
Age: 0+
Code: NCT00567073
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Location: Atlanta GA, Birmingham AL, Columbia SC, Nashville TN,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies